Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cellderived thyroid tumors: A novel diagnostic tool?

Histology and Histopathology

Volumn 27, Issue 3, 2012, Pages 329-336

  Barresi, V ^a   Ieni, A ^a   Tuccari, G ^a   Barresi, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Differential diagnosis; Follicular adenoma; Follicular carcinoma; NGAL; Oncofetal antigen; Thyroid

Indexed keywords

ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; TUMOR MARKER;

ADENOMA; ADULT; AGED; ARTICLE; CANCER INVASION; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ITALY; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ACUTE-PHASE PROTEINS; ADENOMA; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; LIPOCALINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84857712043     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Barresi G. and Tuccari G. (1987). Iron-binding proteins in thyroid tumors. An immunocytochemical study. Pathol. Res. Pract. 182, 344-351.
2. Barresi V., Ieni A., Bolignano D., Magno C., Buemi M. and Barresi G. (2010a). Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. Oncol. Rep. 24, 305-310.
3. Barresi V., Lucianò R., Vitarelli E., Labate A., Tuccari G. and Barresi G. (2010b). Neutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: A stage-specific prognostic factor? Oncol. Lett. 1, 1089-1096.
4. Barresi V., Tuccari G. and Barresi G. (2010c). NGAL immunohistochemical expression in brain primary and metastatic tumors. Clin. Neuropathol. 29, 317-322.
5. Barresi V., Di Gregorio C., Regiani-Bonetti L., Ieni A., Ponz-De Leon M. and Barresi G. (2011). Neutrophil gelatinase-associated lipocalin (NGAL): a new prognostic marker in stage I colorectal carcinoma? Hum. Pathol. [Epub ahead of print]
6. Barroeta J.E., Baloch Z.W., Lal P., Pasha T.L., Zhang P.J. and LiVolsi V.A. (2006) Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr. Pathol. 17, 225-234.
7. Bauer M., Eickhoff J.C., Gould M.N., Mundhenke C., Maas N. and Friedl A. (2008). Neutrophil gelatinase- associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res. Treat. 108, 389-397.
8. Bratt T. (2000). Lipocalins and cancer. Biochim. Biophys. Acta 1482, 318-326.
9. Buergy D., Weber T., Maurer G.D., Mudduluru G., Medved F., Leupold J.H., Brauckhoff M., Post S., Dralle H. and Allgayer H. (2009). Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Int. J. Cancer 125, 894-901.
10. Cho Mar K., Eimoto T., Nagaya S. and Tateyama H. (2006a). Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 48, 801-807.
11. Cho Mar K., Eimoto T., Tateyama H., Arai Y., Fujiyoshi Y. and Hamaguchi M. (2006b). Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions. Histopathology 48, 286-294.
12. Cowland J.B. and Borregaard N. (1997). Molecular charcterization and pattern of tissue expression of the gene for neutrophil gelatinaseassociated lipocalin from humans. Genomics 45, 17-23.
13. De Lellis R.A., Lloyd R.V., Heitz P.U. and Eng C. (2004). Pathology and genetics of tumours of endocrine organs. IARC Press. Lyon.
14. Devireddy L.R., Gazin C., Zhu X. and Green M.R. (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 23,1293-1305.
15. El Demellawy D., Nasr A. and Alowami S. (2008). Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. Diagn. Pathol. 3,5.
16. Elsheikh T.M., Asa S.L., Chan J.K., Heffess C.S., Li Volsi V.A. and Wenig B.M. (2008). Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am. J. Clin. Pathol. 130, 736-744.
17. Erickson L.A. and Lloyd R.V. (2004). Practical markers used in the diagnosis of endocrine tumors. Adv. Anat. Pathol. 11, 175-189.
18. Fernandez C.A., Yan L., Louis G., Yang J., Kutok J.L. and Moses M.A. (2005). The matrix metallo-proteinase-9/neutrophil gelatinase associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Cancer Res. 11, 5390-5395.
19. Ghossein R. (2009). Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch. Pathol. Lab. Med. 83, 683-691.
20. Goetz D.H., Willie S.T., Arme R.S., Bratt T., Borregaard N. and Strong R.K. (2000). Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 39, 1935-1941.
21. Gwira J.A., Wei F. and Ishibe S. (2005). Expression of neutrophil associated-gelatinase lipocalin regulates epithelial morphogenesis in vitro. J. Biol. Chem. 280, 7875-7882.
22. Herrmann M.E., LiVolsi V.A., Pasha T.L., Roberts S.A., Wojcik E.M. and Baloch Z.W. (2002). Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch. Pathol. Lab. Med. 126, 710-713.
23. Hirokawa M., Carney J.A., Goellner J.R., DeLellis R.A., Heffess C.S., Katoh R., Tsujimoto M. and Kakudo K. (2002). Observer variation of encapsulated follicular lesions of the thyroid gland. Am. J. Surg. Pathol. 26, 1508-1514.
24. Hu L., Hittelman W., Lu T., Ji P., Arlinghaus R., Shmulevich I., Hamilton S.R. and Zhang W. (2009). NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab. Invest. 89, 531-548.
25. Iannetti A., Pacifico F., Acquaviva R., Lavorgna A., Crescenzi E., Vascotto C., Tell G., Salzano A.M., Scaloni A., Vuttariello E., Chiappetta G., Formisano S. and Leonardi A. (2008). The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. USA 105, 14058-14063.
26. Le N.T.V. and Richardson D.R. (2002). The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 1603,3146.
27. Lee S., Jilani S.M., Nikolova G.V., Carpizo D. and Iruela-Arispe M.L. (2005). Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691.
28. Prasad M.L., Pellegata N.S., Huang Y., Nagaraja H.N., de la Chapelle A. and Kloos R.T. (2005). Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod. Pathol. 18, 48-57
29. Sahoo S., Hoda S.A., Rosai J. and De Lellis R.A. (2001). Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am. J. Clin. Pathol. 116, 696-702.
30. Saleh H.A., Jin B., Barnwell J. and Alzohaili O. (2010). Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules. Diagn. Pathol. 26, 5-9.
31. Toyokuni S. (2009). Role of iron in carcinogenesis: Cancer as a ferrotoxic disesase. Cancer Sci. 100, 9-16.
32. Tuccari G and Barresi G. (1985). Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchows Arch. 406, 67-74.
33. Yan L., Borregaard N., Kjeldsen L. and Moses M.A. (2001). The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinaseassociated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258-37265.
34. Yang J., Goetz D., Li J.Y., Wang W., Mori K. and Setlik D. (2002). An iron delivery pathway mediated by a lipocalin. Mol. Cell. 10, 1045-1056.
35. Zhu Z., Gandhi M., Nikiforova M.N., Fischer A.H. and Nikiforov Y.E. (2003). Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am. J. Clin. Pathol. 120, 71-77.